Navigation Links
Blood pressure control with ACE inhibitor or diuretic?

An Australian study published in The New England Journal of Medicine has challenged the American ALLHAT trial that showed diuretics were superior to ACE (angiotensin-converting enzyme) inhibitors and calcium channel blockers in controlling blood pressure. The Australian study included 6,083 people who were mostly white. Blood pressure reduction was the same in those who took a diuretic and those who took an ACE inhibitor. The incidence of stroke was the same in both// groups, but the number of deaths from cardiovascular disease was 11 percent lower in the ACE inhibitor group.

Study author Dr. Christopher M. Reid of the Baker Heart Institute in Melbourne said that the differing results could have been due to the difference in the ethnic makeup of the two trials. He explained that thirty percent of the ALLHAT subjects were black Americans, who are known not to respond to ACE inhibitors, while the Australian study comprised mostly of whites. However, he also added that for most patients the conflicting results of the two trials will not make much difference, and that almost all people with high blood pressure need to take more than one drug. Reid said that their study recommended starting with an ACE inhibitor and then using a diuretic, if one is over the age of 65, while the ALLHAT study recommended starting with a diuretic and then adding a calcium channel blocker or an ACE inhibitor. Reid concluded that further research will lead to a situation where there will be specific recommendations for various groups of patients like the elderly, the diabetics, and the ethnic groups. He also stated that irrespective of the studies, the choice of agent that best suits the patient and the agent with which they are most compliant and comfortable would be the agent of choice.


'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... ... the perfect opportunity for the nation to come together to ... basketball bracket – with its favorite fruit – apples! To ... apple lovers to join the “Apple Madness” bracket tournament – ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing ... sit stand solutions representative to the Minneapolis Home and Garden Show which is being ... that is garnering national attention is the Minneapolis Convention Center. , From its ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society demands ... the sharpest brain. , Power On, a mental performance enhancer from Modus Nutrition, ... brain. Each capsule contains Cognizin® Citicoline, a branded form of the brain health ...
(Date:2/22/2017)... ... 2017 , ... Secure Exchange Solutions, the leading provider of ... health information exchanges, physicians and patients, announced today that SES Direct earned the ... IT Module Certification via Drummond Group LLC, an Authorized Certification Body (ACB). This ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leverages advanced data analytics to accurately understand each Medicare Advantage member’s risk, ... a given population. This new solution helps transform the HCC Risk Adjustment ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 On Wednesday, ... day as four out of nine sectors finished the trading ... managed a flat closing. Major US indices were also mixed ... the day at 5,860.63, slightly down by 0.09%; the Dow ... and the S&P 500 closed at 2,362.82, down 0.11%. This ...
(Date:2/23/2017)... , February 23, 2017 ML Capital ... in Colorado Highlife Tours , a ... plan in partnership with Puration, Inc. (USOTC: PURA) to enter ... cannabis tours product. The Colorado Highlife Tours acquisition announced today is ... tourism strategy. ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, 2017 ... today announced its year end 2016 financial results.  ... 2017, OncoGenex, and Achieve Life Science, Inc., a privately held ... a definitive merger agreement under which OncoGenex will acquire ... proposed merger, Achieve,s stockholders are expected to own 75% ...
Breaking Medicine Technology: